Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 664 | 293 | 0.2841 | 0.2946 | 0.4413 | 0.4049 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 501 | 174 | 0.2504 | 0.2538 | 0.3473 | 0.3464 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 465 | 150 | 0.2413 | 0.2538 | 0.3226 | 0.3464 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 558 | 206 | 0.2696 | 0.2538 | 0.3692 | 0.3464 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 840 | 273 | 0.4343 | 0.3712 | 0.3250 | 0.3204 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 724 | 231 | 0.3776 | 0.3712 | 0.3191 | 0.3204 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 577 | 183 | 0.3018 | 0.3712 | 0.3172 | 0.3204 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 506 | 105 | 0.3071 | 0.2918 | 0.2075 | 0.1993 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 471 | 92 | 0.2903 | 0.2918 | 0.1953 | 0.1993 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 451 | 88 | 0.2780 | 0.2918 | 0.1951 | 0.1993 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 1665 | 69 | 0.9834 | 1.0000 | 0.0414 | 0.0422 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 1798 | 71 | 1.0641 | 1.0000 | 0.0395 | 0.0422 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 1620 | 74 | 0.9526 | 1.0000 | 0.0457 | 0.0422 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 1508 | 67 | 0.8879 | 1.1047 | 0.0444 | 0.0462 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 2014 | 89 | 1.1861 | 1.1047 | 0.0442 | 0.0462 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 2119 | 106 | 1.2403 | 1.1047 | 0.0500 | 0.0462 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 1089 | 33 | 0.6506 | 0.6001 | 0.0303 | 0.0364 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 1033 | 43 | 0.6100 | 0.6001 | 0.0416 | 0.0364 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 910 | 34 | 0.5397 | 0.6001 | 0.0374 | 0.0364 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1027 | 40 | 0.6081 | 0.4909 | 0.0389 | 0.0363 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 837 | 30 | 0.4972 | 0.4909 | 0.0358 | 0.0363 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 617 | 21 | 0.3672 | 0.4909 | 0.0340 | 0.0363 |
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 1045 | 59 | 0.6075 | 0.6825 | 0.0565 | 0.0631 |
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 1285 | 81 | 0.7418 | 0.6825 | 0.0630 | 0.0631 |
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 1218 | 85 | 0.6981 | 0.6825 | 0.0698 | 0.0631 |